A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, Billette de Villemeur T, Berger MG.
Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441.
Gene Therapy of Sphingolipid Metabolic Disorders.
Shaimardanova AA, Solovyeva VV, Issa SS, Rizvanov AA.
Int J Mol Sci. 2023 Feb 11;24(4):3627. doi: 10.3390/ijms24043627.
Niemann-Pick type C disease: The atypical sphingolipidosis.
Newton J, Milstien S, Spiegel S.
Adv Biol Regul. 2018 Dec;70:82-88. doi: 10.1016/j.jbior.2018.08.001. Epub 2018 Aug 28.
[Sphingolipidosis].
Kobayashi T.
Fukuoka Igaku Zasshi. 1992 Apr;83(4):151-5.
Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification.
Schlotawa L, Adang LA, Radhakrishnan K, Ahrens-Nicklas RC.
Int J Mol Sci. 2020 May 13;21(10):3448. doi: 10.3390/ijms21103448.
[Sphingolipidosis in childhood].
Carnevale F.
Pediatria (Napoli). 1968 Jun 20;76(3):438-55.
[Fabry disease].
Stephan F, Haber R.
Ann Dermatol Venereol. 2017 Feb;144(2):137-146. doi: 10.1016/j.annder.2016.10.010. Epub 2017 Jan 16.
[Sphingolipidosis and lipid storage diseases].
Inui K.
Ryoikibetsu Shokogun Shirizu. 1995;(8):358-61.
Sphingolipidoses.
Sandhoff K.
J Clin Pathol Suppl (R Coll Pathol). 1974;8:94-105.
Sphingolipidoses.
Yatsu FM.
Calif Med. 1971 Apr;114(4):1-6.
